Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2024-12-10 00:00:00 ET · period of report 2024-12-08 · accession 0001367644-24-000191 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-12-10 | 2024-12-08 | EBS | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $9.01 | -18.7K | 144.5K | -11% | -$168.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-08 | F | D | 18,674 | $9.01 | 144,460 | D | — | — | (F1) Represents shares of common stock withheld to pay taxes. |